Synergistic integration of regional and systemic therapies in uveal melanoma

Competing interests

S.A.K. has had consulting roles for Delcath, Ideaya, Immunocore, Regeneron and Replimune. R.D.C. has had consulting roles for Caper Labs, Castle Biosciences, Delcath, Ideaya, Immunocore, iOnctura, Mural Oncology, Pierre Fabre and Trisalus.

Comments (0)

No login
gif